Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ramsay Health Care Limited (RHC.AX)
AUD42.98
+0.56 (+1.32%)
AU ASX Healthcare Medical - Care Facilities
Address
126 Phillip Street 2000
Sydney, NSW, AU
Sydney, NSW, AU
CEO
Natalie Davis
Website
ramsayhealth.com
IPO
1997-10-01
ISIN AU000000RHC8
Also trades on
Australian Securities Exchange · RHC.AX (AUD)
Other OTC · RMSYF (USD)
Other OTC · RMYHY (USD)
Description
Ramsay Health Care Limited is a prominent healthcare provider that manages and possesses hospitals. The company delivers medical services to both publicly funded and privately insured individuals. It maintains a substantial international presence, operating roughly 532 facilities across the Asia Pacific region, the United Kingdom, France, and the Nordic nations. Founded in 1964, its corporate headquarters are situated in Sydney, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD42.98
+0.56 (+1.32%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
719.6K
Beta
0.60
Float Shares
182.35M
Free Float %
79.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.24% | -2.14% | -4.85% | -13.88% | +0.76% | +7.95% | -1.88% | -35.35% | -41.59% | -49.02% | +1,601.38% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
42.98
DCF (Unlevered)
272.39
+533.8%
DCF (Levered)
228.73
+432.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
29% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 2 | 0 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.40
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+6.8% Q4'25: +15.5% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%-99.2% Q4'25: -79.9% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+2.3% ★ Q4'25: -0.7% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+5.8% Q4'25: +5.2% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+3.6% Q4'25: +5.3% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.5% Q4'25: +0.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×7.64× Q4'25: 4.06× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2001 actual |
Jun 2002 actual |
Jun 2003 actual |
Jun 2004 actual |
Jun 2005 actual |
Jun 2006 actual |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 14 Rev. Ana. 11 EPS Ana. |
Jun 2027 14 Rev. Ana. 11 EPS Ana. |
Jun 2028 13 Rev. Ana. 9 EPS Ana. |
Jun 2029 9 Rev. Ana. 3 EPS Ana. |
Jun 2030 12 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
377.01M
est: 368.75M (+2.2%)
|
549.79M
est: 538.54M (+2.1%)
|
655.50M
est: 651.24M (+0.7%)
|
760.84M
est: 763.38M (-0.3%)
|
1.12B
est: 1.17B (-4.0%)
|
1.98B
est: 2.15B (-7.8%)
|
2.09B
est: 2.13B (-2.2%)
|
2.65B
est: 2.69B (-1.5%)
|
3.20B
est: 3.28B (-2.5%)
|
3.37B
est: 3.49B (-3.4%)
|
3.69B
est: 3.83B (-3.5%)
|
3.92B
est: 4.04B (-3.1%)
|
4.13B
est: 4.27B (-3.2%)
|
4.88B
est: 4.92B (-0.9%)
|
7.32B
est: 7.37B (-0.7%)
|
8.65B
est: 8.55B (+1.1%)
|
8.67B
est: 8.95B (-3.2%)
|
9.14B
est: 9.11B (+0.3%)
|
11.51B
est: 11.39B (+1.1%)
|
11.93B
est: 12.08B (-1.2%)
|
12.86B
est: 12.99B (-1.0%)
|
13.08B
est: 13.65B (-4.2%)
|
14.96B
est: 15.31B (-2.3%)
|
16.66B
est: 16.70B (-0.3%)
|
17.79B
est: 17.88B (-0.5%)
|
18.91B
18.59B – 19.29B
+5.8% YoY
|
19.48B
19.04B – 20.14B
+3.0% YoY
|
20.33B
20.32B – 20.34B
+4.4% YoY
|
21.45B
21.02B – 22.03B
+5.5% YoY
|
22.45B
22.00B – 23.06B
+4.7% YoY
|
| EBITDA |
55.34M
est: -15.77M (+451.0%)
|
83.58M
est: 62.50M (+33.7%)
|
91.68M
est: 31.83M (+188.0%)
|
101.26M
est: 45.72M (+121.5%)
|
163.55M
est: 61.21M (+167.2%)
|
253.61M
est: -3.68M (+6,986.2%)
|
280.31M
est: 53.28M (+426.1%)
|
316.40M
est: 124.89M (+153.4%)
|
360.16M
est: 61.01M (+490.3%)
|
437.60M
est: 60.63M (+621.7%)
|
504.03M
est: 157.73M (+219.6%)
|
566.91M
est: 228.02M (+148.6%)
|
603.42M
est: 265.06M (+127.7%)
|
686.41M
est: 361.79M (+89.7%)
|
1.06B
est: 559.44M (+89.9%)
|
1.21B
est: 574.15M (+110.5%)
|
1.24B
est: 550.34M (+125.9%)
|
1.10B
est: 585.24M (+88.0%)
|
1.50B
est: 606.05M (+147.6%)
|
1.54B
est: 709.15M (+117.8%)
|
1.80B
est: 35.91M (+4,926.5%)
|
1.61B
est: 39.34M (+3,999.6%)
|
1.78B
est: 40.81M (+4,255.5%)
|
1.81B
est: 41.91M (+4,209.6%)
|
1.59B
est: 2.10B (-24.3%)
|
2.20B
2.16B – 2.24B
+4.3% YoY
|
2.26B
2.21B – 2.34B
+3.0% YoY
|
2.36B
2.36B – 2.36B
+4.4% YoY
|
2.49B
2.44B – 2.56B
+5.5% YoY
|
2.61B
2.55B – 2.68B
+4.7% YoY
|
| EBIT |
35.54M
est: 31.53M (+12.7%)
|
60.69M
est: -10.02M (+705.6%)
|
66.96M
est: 69.78M (-4.0%)
|
72.95M
est: 78.54M (-7.1%)
|
106.80M
est: 111.71M (-4.4%)
|
195.80M
est: 189.67M (+3.2%)
|
217.09M
est: 193.39M (+12.3%)
|
228.22M
est: 273.74M (-16.6%)
|
250.09M
est: 278.20M (-10.1%)
|
299.30M
est: 265.94M (+12.5%)
|
368.75M
est: 325.32M (+13.4%)
|
418.35M
est: 388.16M (+7.8%)
|
454.72M
est: 436.14M (+4.3%)
|
518.42M
est: 523.10M (-0.9%)
|
761.64M
est: 756.09M (+0.7%)
|
837.75M
est: 871.43M (-3.9%)
|
877.32M
est: 875.16M (+0.2%)
|
708.06M
est: 865.41M (-18.2%)
|
1.02B
est: 883.83M (+14.9%)
|
651.60M
est: 1.03B (-36.9%)
|
905.50M
est: 922.68M (-1.9%)
|
685.30M
est: 1.01B (-32.2%)
|
788.30M
est: 1.05B (-24.8%)
|
1.00B
est: 1.08B (-6.7%)
|
1.03B
est: 1.00B (+3.0%)
|
1.05B
1.03B – 1.07B
+4.3% YoY
|
1.08B
1.05B – 1.12B
+3.0% YoY
|
1.13B
1.13B – 1.13B
+4.4% YoY
|
1.19B
1.16B – 1.22B
+5.5% YoY
|
1.24B
1.22B – 1.28B
+4.7% YoY
|
| Net Income |
16.00M
est: 7.88M (+103.0%)
|
31.07M
est: 22.91M (+35.6%)
|
37.06M
est: 37.95M (-2.4%)
|
38.35M
est: 43.37M (-11.6%)
|
30.07M
est: 58.15M (-48.3%)
|
87.59M
est: 55.24M (+58.6%)
|
107.06M
est: 86.83M (+23.3%)
|
92.20M
est: 134.98M (-31.7%)
|
106.47M
est: 112.26M (-5.2%)
|
148.28M
est: 112.76M (+31.5%)
|
189.39M
est: 162.11M (+16.8%)
|
244.11M
est: 209.99M (+16.2%)
|
266.40M
est: 257.67M (+3.4%)
|
303.76M
est: 306.48M (-0.9%)
|
371.81M
est: 463.41M (-19.8%)
|
437.34M
est: 447.59M (-2.3%)
|
488.95M
est: 474.16M (+3.1%)
|
376.02M
est: 493.30M (-23.8%)
|
545.47M
est: 484.98M (+12.5%)
|
284.00M
est: 582.84M (-51.3%)
|
449.00M
est: 304.41M (+47.5%)
|
274.00M
est: 333.54M (-17.9%)
|
298.10M
est: 265.20M (+12.4%)
|
888.70M
est: 253.90M (+250.0%)
|
24.00M
est: 277.12M (-91.3%)
|
302.17M
264.73M – 343.68M
+9.0% YoY
|
386.90M
335.13M – 437.03M
+28.0% YoY
|
462.32M
391.63M – 514.71M
+19.5% YoY
|
494.50M
481.69M – 511.90M
+7.0% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
224.94M
est: 210.58M (+6.8%)
|
311.66M
est: 329.28M (-5.4%)
|
387.43M
est: 381.95M (+1.4%)
|
445.59M
est: 453.64M (-1.8%)
|
653.74M
est: 682.52M (-4.2%)
|
1.13B
est: 1.54B (-26.4%)
|
1.20B
est: 1.12B (+7.6%)
|
1.54B
est: 1.52B (+1.4%)
|
1.82B
est: 1.88B (-3.2%)
|
1.90B
est: 1.94B (-2.2%)
|
2.07B
est: 2.08B (-0.6%)
|
2.20B
est: 2.20B (+0.1%)
|
2.33B
est: 2.33B (+0.0%)
|
2.83B
est: 2.68B (+5.4%)
|
4.34B
est: 4.31B (+0.7%)
|
5.17B
est: 5.04B (+2.6%)
|
5.21B
est: 5.44B (-4.3%)
|
5.66B
est: 5.29B (+6.9%)
|
7.17B
est: 7.07B (+1.5%)
|
7.57B
est: 7.66B (-1.2%)
|
7.82B
est: 8.12B (-3.7%)
|
8.31B
est: 8.89B (-6.6%)
|
9.43B
est: 9.22B (+2.2%)
|
10.32B
est: 9.47B (+9.0%)
|
—
est: 10.02B (-100.0%)
|
9.43B
9.27B – 9.62B
-5.9% YoY
|
9.71B
9.49B – 10.04B
+3.0% YoY
|
10.13B
10.13B – 10.14B
+4.4% YoY
|
10.69B
10.48B – 10.98B
+5.5% YoY
|
11.19B
10.97B – 11.50B
+4.7% YoY
|
| EPS |
0.14
est: 0.14 (+3.6%)
|
0.24
est: 0.24 (+1.9%)
|
0.29
est: 0.29 (-0.4%)
|
0.30
est: 0.33 (-8.0%)
|
0.22
est: 0.33 (-33.1%)
|
0.43
est: 0.48 (-10.3%)
|
0.53
est: 0.57 (-6.2%)
|
0.43
est: 0.61 (-29.3%)
|
0.51
est: 0.74 (-30.8%)
|
0.69
est: 0.84 (-17.5%)
|
0.91
est: 1.03 (-11.3%)
|
1.13
est: 1.19 (-5.2%)
|
1.25
est: 1.37 (-8.7%)
|
1.44
est: 1.64 (-12.2%)
|
1.85
est: 1.98 (-6.8%)
|
2.18
est: 2.29 (-4.8%)
|
2.37
est: 2.63 (-10.0%)
|
1.93
est: 2.80 (-31.2%)
|
2.64
est: 2.86 (-7.8%)
|
1.31
est: 1.73 (-24.2%)
|
1.93
est: 2.00 (-3.3%)
|
1.16
est: 1.40 (-17.2%)
|
1.25
est: 1.49 (-16.2%)
|
3.82
est: 1.25 (+206.5%)
|
0.03
est: 1.32 (-97.8%)
|
1.36
1.15 – 1.49
+2.9% YoY
|
1.62
1.46 – 1.90
+19.0% YoY
|
1.94
1.70 – 2.24
+19.6% YoY
|
2.15
2.09 – 2.23
+10.9% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
5.16B
OE per share TTM
22.45
Owner's Yield
60.42%
Maintenance CapEx ratio
239.59%
Maint CapEx / Avg PPE
64.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
11.5K
Shares Outstanding
229.93M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Natalie Davis | MD, Group Chief Executive Officer & Director | 2M | female |
| Anthony Myles Neilson | Group Chief Financial Officer | 2M | male |
| Brindan Suresh | Group Executive Health and Strategy | 955.1K | — |
| Henrietta Rowe BECON | Group Executive Legal & Company Secretariat | — | female |
| John Doulis | Group Executive Technology & Digital | — | — |
| Kelly Hibbins | Group Head of Investor Relations | — | female |
| Nick Costa | MD of Ramsay UK Hospitals & Acting MD Elysium | — | male |
| Pascal Roche | Managing Director Ramsay Sante | — | male |
| Stuart Winters | Chief Operating Officer - Australia | — | male |
| Barbara Cox | Chief Brand & Communications Officer | — | — |
| Colleen Harris | Group Executive People | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RHC.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
